Cytotoxicity of chloroquine in isolated rat hepatocytes

Journal of Applied Toxicology

Volumn 27, Issue 4, 2007, Pages 322-326

  Jamshidzadeh, Akram ^a   Niknahad, Hossein ^a   Kashafi, Hamed ^a  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Chloroquine; Cytochrome P 450; GSH; Hepatotoxicity; Lipid peroxidation

Indexed keywords

ANTIMALARIAL AGENT; ANTIOXIDANT; ANTIRHEUMATIC AGENT; CHLOROQUINE; CIMETIDINE; CYTOCHROME P450 INHIBITOR; GLUTATHIONE; QUINIDINE; QUINOLINE DERIVATIVE; TROLEANDOMYCIN;

ANIMAL CELL; ARTICLE; CELL DEATH; CELL ISOLATION; CONTROLLED STUDY; CYTOTOXICITY; LIPID PEROXIDATION; LIVER CELL; LIVER TOXICITY; MALE; METABOLIC INHIBITION; METABOLITE; NONHUMAN; PRIORITY JOURNAL; RAT;

ADENOSINE TRIPHOSPHATE; ANIMALS; ANTIOXIDANTS; ANTIRHEUMATIC AGENTS; ASCORBIC ACID; BENZOCYCLOHEPTENES; CELLS, CULTURED; CHLOROQUINE; CYTOCHROME P-450 ENZYME SYSTEM; CYTOTOXINS; DIHYDROXYACETONE; DOSE-RESPONSE RELATIONSHIP, DRUG; ENZYME ACTIVATORS; FREE RADICAL SCAVENGERS; FRUCTOSE; GLUTATHIONE; HEPATOCYTES; HEPTANES; LIPID PEROXIDATION; MALE; RATS; RATS, SPRAGUE-DAWLEY; THIOBARBITURIC ACID REACTIVE SUBSTANCES; VITAMINS;

RATTUS;

EID: 34447518685     PISSN: 0260437X     EISSN: 10991263     Source Type: Journal    
DOI: 10.1002/jat.1194     Document Type: Article

References (28)

1. Abdel-Gayoum AA, Haider SS, Tass FM, Ghawarsha K. 1992. Effect of chloroquine on some carbohydrate metabolic pathways: contents of GHS, ascorbate and lipid peroxidation in the rats. Pharmacol. Toxicol. 71: 161-164.
2. Bellomo G, Mirabelli F, DiMonte D, Richelmi P, Thor H, Orrenius C, Orrenius S. 1987. Formation and reduction of glutathione-protein mixed disulfides during oxidative stress. Biochem. Pharmacol. 36: 1313-1320.
3. Dass EE, Shah KK. 2000. Paracetamol and conventional antimalarial drugs induced hepatotoxicity and its protection by methionine in rats. Indian J. Exp. Biol. 38: 1138-1142.
4. Debra KF, Megan NL. 1999. Quinine induced hepatotoxicity. Ann. Pharmacother. 33: 32-34.
5. Ellman G. 1959. Tissue sulphydryl groups. Arch. Biochem. Biophys. 82: 70-77.
6. Farombi EO. 2000. Influence of amodiaquine treatment on microsomal lipid peroxidation and antioxidant defense system of rats. Pharmacol. Toxicol. 87: 249-254.
7. Farombi EO, Emerole GO. 1998. Interference of common antimalarial drugs with some hepatic microsomal components and drug metabolism: potential implications for toxicity. South Afr. J. Sci. 94: 303-304.
8. Halliwell B. 1990. How to characterize a biological antioxidant. Free Radic. Res. Commun. 9: 1-32.
9. Kedderis GL. 1996. Biochemical basis of hepatocellular injury. Toxicol. Pathol. 24: 77-83.
10. Khan S, O'Brien PJ. 1991. 1-Bromoalkanes as new potent nontoxic glutathione depletors in isolated rat hepatocytes. Biochem. Biophys. Res. Commun. 179: 436-441.
11. Kim KA, Park JY, Lee JS, Lim S. 2003. Cytochrome p450 2C8 and CYP3A4/5 are involved in chloroquine metabolism in human liver microsomes. Arch. Pharm. Res. 26: 631-637.
12. Klassen CD. 2005. Cassarett & Doull's Toxicology, 7th edn. Mc Graw-Hill: USA.
13. Kleinman WA, Richie JPJR. 2000. Status of glutathione and other thiols and disulfides in human plasma. Biochem. Pharmacol. 60: 19-29.
14. Koranda FC. 1981. Antimalarials. J. Am. Acta. Dermatol. 4: 650-655.
15. Lee W. 2003. Drug-induced hepatotoxicity. N. Engl. J. Med. 349: 474-485.
16. Li XQ, Bjorkman A, Andersson TB, Gustafsson LL, Masimirembwa CM. 2003. Identification of human cytochrome p(450)s that metabolize anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitro data. Eur. J. Clin. Pharmacol. 59: 429-442.
17. Liu AC. 1995. Hepatotoxic reaction to chloroquine phosphate in a patient with previously unrecognized porphyria cutanea tarda. West. J. Med. 162: 548-551.
18. Moldeus P, Hogberg J, Orrenius S. 1978. Isolation and use of liver cells. Methods Enzymol. 52: 60-71.
19. Nakagawa Y, Tayana S, Moore GA, Moldeus P. 1992. Relationship between metabolism and cytotoxicity of ortho-phenylphenol in isolated rat hepatocytes. Biochem. Pharmacol. 43: 1431-1437.
20. Pari L, Murugavel P. 2004. Protective effect of α-lipoic acid against chloroquine-induced hepatotoxicity in rats. J. Appl. Toxicol. 24: 21-26.
21. Projean D, Baune B, Farinotti R, Flinois JP, Beaune P, Taburet AM, Ducharme J. 2003. In vitro metabolism of chloroquine: identification of CYP2C8, CYP3A4, and CYP2D6 as the main isoforms catalyzing N-desethylchloroquine formation. Drug Metab. Dispos. 31: 748-754.
22. Reed DJ. 1990. Glutathione: toxicological implications. Annu. Rev. Pharmacol. Toxicol. 30: 603-631.
23. Smith MT, Thor H, Hartizell P, Orrenius S. 1982. The measurement of lipid peroxidation in isolated hepatocytes. Biochem. Pharmacol. 31: 19-26.
24. Sweetman SC. 2005. Martindale: The Complete Drug Reference, 34rd edn. The Pharmaceutical Press: London; 444-464.
25. Wang R. 1995. Hydroxychloroquine cardiotoxicity. Clin. Toxicol. 33: 475-486.
26. Wielgo-Polanin R, Lagarce L, Gautron E, Diquet B, Lainn'e-Cessac P. 2005. Hepatotoxicity associated with the use of a fixed combination of chloroquine and proguanil. Int. J. Antimicrob. Agents 26: 176-178.
27. Wilkinson R, Mahatane J, Wade P, Paevol G. 1993. Chloroquine poisoning. Br. Med. J. 32: 307-504.
28. Zhao XJ, Ishizaki T. 1997. The in vitro hepatic metabolism of quinine in mice, rats and dogs: comparison with human liver microsomes. J. Pharmacol. Exp. Ther. 283: 1168-1176.